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ABSTRACT 
This investigation has been conducted to study the protective effect 
of water extract of Nigella sativa (NS) against Diethylnitrosamine (DEN)    
induced hepatocarcinogenesis in rats. Seventy five Wistar rats, divided 
into five equal groups, were used. Group A rats were dosed with DEN 
(200 mg/ kg) intra-peritoneally; 12 hours later the rats were given NS 
water extract orally at a dose of 6 g/ kg/ day for 8 weeks. Group B rats 
were injected with DEN only and stayed for 8 weeks (positive control). 
Group C rats received NS extract daily per os for 8 weeks (negative 
control). Group D rats were dosed with DEN and after 6 weeks they 
received NS extract daily for another 6 weeks. Group E rats were 
administered with NS extract daily for 6 weeks, then dosed with DEN, 
and kept for 6 weeks. The experimental rats were subjected to partial 
hepatectomy (PH) two weeks after the administration of DEN, except 
those of group C in which PH was done two weeks after the 
administration of NS extract. All rats were euthanized at the end of the 
experiments and postmortem examination was carried out. Sample  from 
livers and lungs were taken  in 10% neutral formaline for histopathology 
and immunohistochemistry. The results of liver histopathology in all 
groups revealed the presence of degenerative changes in the form of 
hepatocyte cytoplasmic vacuolations. These were mild to moderate in 
groups A, D & E but marked in group B rats. In the negative control 
group (C) the changes were minimal. Cell dysplasia, seen as cellular 
pleomorphism, nuclear hyperchromacia, presence of binucleate and 
multinucleate cell, was observed in all groups receiving DEN; these 
changes were more obvious in group B and are considered as 
premalignancy changes. No necrotic or inflammatory alterations were 
noticed. Immunohistochemistry was done to identify the Glutathione-S 
Transpherase Placental form (GST-P) positive foci, as tumor marker, in 
all liver sections using the avidin-biotin complex method. There was a 
significant decrease in the number of positive foci of GST-P in liver 
sections of the test groups particularly groups A and E when compared 
with group B receiving only DEN. It was concluded that NS water extract 
could have a protective effect against DEN-mediated 
hepatocarcinogenesis in rats if given within few hours after DEN 
injection or 6week before injection of DEN . 
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 اﻟﻤﺴﺘﺨﻠﺺ
 
أﺟﺮﻳѧѧﺖ هѧѧﺬﻩ اﻟﺪراﺳѧѧﺔ ﻟﻤﻌﺮﻓѧѧﺔ اﻟﺘѧѧﺎﺛﻴﺮ اﻟﻮﻗѧѧﺎﺋﻰ ﻟﻠﻤѧѧﺴﺘﺨﻠﺺ اﻟﻤѧѧﺎﺋﻰ ﻟﻠﺤﺒѧѧﺔ اﻟѧѧﺴﻮداء ﺿѧѧﺪ 
إﺳﺘﺨﺪﻣﺖ ﺧﻤﺲ وﺳﺒﻌﻴﻦ  ﺟѧﺮذًا . ﺗﺴﺮﻃﻦ اﻟﻜﺒﺪ اﻟﻤﺤﺪث ﺑﻤﺎدة ﺛﻨﺎﺋﻰ إﺛﻴﻞ اﻟﻨﺘﺮوزاﻣﻴﻦ ﻓﻰ اﻟﺠﺮذان 
  ﺑﻤѧѧﺎدة ﺛﻨѧѧﺎﺋﻲ اﻳﺜﻴѧѧﻞ  أﺗѧѧﻢ ﺣﻘѧѧﻦ ﺟѧѧﺮذان  اﻟﻤﺠﻤﻮﻋѧѧﺔ . ﺑﻌѧѧﺪ ﺗﻘѧѧﺴﻴﻤﻬﺎ ﻟﺨﻤѧѧﺲ ﻣﺠﻤﻮﻋѧѧﺎت ﻣﺘѧѧﺴﺎوﻳﺔ
 ﺳﺎﻋﺔ ﺟﺮﻋﺖ ﺑﻤѧﺴﺘﺨﻠﺺ اﻟﺤﺒѧﺔ اﻟѧﺴﻮداء اﻟﻤѧﺎﺋﻲ 21زاﻣﻴﻦ  اﻟﻤﺴﺮﻃﻨﺔ داﺧﻞ اﻟﺼﻔﺎق وﺑﻌﺪ اﻟﻨﻴﺘﺮو
آﺸﺎهﺪ ) أﺳﺎﺑﻴﻊ 8 ﺑﺎﻟﻤﺎدة اﻟﻤﺴﺮﻃﻨﺔ وﺗﺮآﺖ ﻟﻤﺪة  ب ﺣﻘﻨﺖ ﺟﺮذان اﻟﻤﺠﻤﻮﻋﺔ .  أﺳﺎﺑﻴﻊ 8ﻳﻮﻣﻴﺎ ﻟﻤﺪة 
آѧﺸﺎهﺪ ) أﺳѧﺎﺑﻴﻊ 8 ﺑﻤѧﺴﺘﺨﻠﺺ اﻟﺤﺒѧﺔ اﻟѧﺴﻮداء ﻳﻮﻣﻴѧﺎ ﻟﻤѧﺪة جﺟﺮﻋѧﺖ ﺟѧﺮذان اﻟﻤﺠﻤﻮﻋѧﺔ (. إﻳﺠѧﺎﺑﻲ
 أﺳѧﺎﺑﻴﻊ ﺟﺮﻋѧﺖ ﺑﻤѧﺴﺘﺨﻠﺺ اﻟﺤﺒѧﺔ 6  ﺑﺎﻟﻤѧﺎدة اﻟﻤѧﺴﺮﻃﻨﺔ وﺑﻌѧﺪ دذان اﻟﻤﺠﻤﻮﻋѧﺔ ﺣﻘﻨﺖ ﺟѧﺮ (. ﺳﻠﺒﻲ
 6  ﺑﻤѧﺴﺘﺨﻠﺺ اﻟﺤﺒѧﺔ اﻟѧﺴﻮداء ﻟﻤѧﺪة  هﺟﺮﻋѧﺖ ﺟѧﺮذان  اﻟﻤﺠﻤﻮﻋѧﺔ .  أﺳﺎﺑﻴﻊ اﺧﺮي 6اﻟﺴﻮداء  ﻟﻤﺪة 
اﺧѧﻀﻌﺖ اﻟﺠѧﺮذان ﻟﻌﻤﻠﻴѧﺔ ﻗﻄѧﻊ ﺟﺰﺋѧﻲ . أﺳѧﺎﺑﻴﻊ اﺧѧﺮي 6أﺳﺎﺑﻴﻊ ﺛﻢ ﺣﻘﻨﺖ ﺑﺎﻟﻤﺎدة اﻟﻤﺴﺮﻃﻨﺔ وﺑﻘﻴﺖ 
 واﻟﺘѧﻲ اﺟﺮﻳѧﺖ ﻟﻬѧﺎ  جﻟﻤѧﺎدة اﻟﻤѧﺴﺮﻃﻨﺔ ﻣѧﺎ ﻋѧﺪا ﺟѧﺮذان  اﻟﻤﺠﻤﻮﻋѧﺔﻟﻠﻜﺒѧﺪ ﺑﻌѧﺪ أﺳѧﺒﻮﻋﻴﻦ ﻣѧﻦ ﺣﻘѧﻦ ا
ﺑﻨﻬﺎﻳѧѧﺔ اﻟﺘﺠﺮﺑѧѧﺔ ﻗﺘﻠѧѧﺖ . ﺴﺘﺨﻠﺺ  اﻟﺤﺒѧѧﺔ اﻟѧѧﺴﻮداء ﻋﻤﻠﻴѧѧﺔ اﻟﻘﻄѧѧﻊ ﺑﻌѧѧﺪ أﺳѧѧﺒﻮﻋﻴﻦ ﻣѧѧﻦ ﺑﺪاﻳѧѧﺔ ﺗﺠﺮﻳѧѧﻊ ﻣѧѧ 
ﻣﺤﻠѧѧﻮل % 01وأﺧѧѧﺬت ﻋﻴﻨѧѧﺎت  ﻣѧѧﻦ اﻟﻜﺒѧѧﺪ و اﻟﺮﺋѧѧﻪ ﻓѧѧﻰ  . اﻟﺠѧѧﺮذان ﻗѧѧﺘًﻼ رﺣﻴﻤѧѧًﺎ وﺗѧѧﻢ ﺗѧѧﺸﺮﻳﺤﻬﺎ 
اﻇﻬѧﺮت .اﻟﻔﻮرﻣﺎﻟﻴﻦ اﻟﻤﺘﻌﺎدل ﻟﻠﻔﺤѧﺺ اﻟﻨѧﺴﻴﺠﻰ اﻟﻤﺮﺿѧﻰ واﻟﻔﺤѧﺺ اﻟﻜﻴﻤﻴѧﺎﺋﻰ اﻟﻨѧﺴﻴﺠﻰ اﻟﻤﻨѧﺎﻋﻰ 
 ﺗﻐﻴѧﺮات ﺗﻨﻜѧﺴﻴﺔ ﻋﻠѧﻲ ﺷѧﻜﻞ ﻧﺘﺎﺋﺞ ﻓﺤﻮﺻﺎت اﻷﻧѧﺴﺠﺔ اﻟﻤﺮﻳѧﻀﺔ ﻟﻠﻜﺒѧﺪ ﻓѧﻲ آѧﻞ اﻟﻤﺠﻤﻮﻋѧﺎت وﺟѧﻮد 
  ه، د، أآﺎﻧѧﺖ هѧﺬﻩ ﺧﻔﻴﻔѧﺔ اﻟѧﻲ ﻣﺘﻮﺳѧﻄﺔ ﻓѧﻰ اﻟﻤﺠﻤﻮﻋѧﺎت .ﻓﺠѧﻮات ﻓѧﻲ ﺳѧﻴﺘﻮﺑﻼزم اﻟﺨﻼﻳѧﺎ اﻟﻜﺒﺪﻳѧﺔ 
وﻗﺪ آﺎﻧﺖ هﺬﻩ اﻟﺘﻐﻴѧﺮات أﻗѧﻞ ﻇﻬѧﻮرا ﻓѧﻲ ﻣﺠﻤﻮﻋѧﺔ  اﻟѧﺸﺎهﺪ  . بوﻟﻜﻨﻬﺎ آﺎﻧﺖ آﺒﻴﺮة ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ 
ﻷﻧﻮﻳѧﺔ ﻣѧﻊ  وﺟѧﻮد ﺧﻼﻳѧﺎ ﻟﻮﺣﻆ  ﺧﻠﻞ ﺗﻨﺴﺞ اﻟﺨﻠﻴﺔ ﻓﻲ ﺻﻮرة ﺗﻌﺪد اﺷﻜﺎل اﻟﺨﻼﻳѧﺎ و ا (. ج)اﻟﺴﻠﺒﻰ  
ﺑﻨﻮاﺗﻴﻦ  أو ﺧﻼﻳﺎ ﻣﺘﻌﺪدة اﻷﻧﻮﻳﺔ ﻓﻲ آﻞ اﻟﻤﺠﻤﻮﻋﺎت  اﻟﺘﻲ ﺣﻘﻨﺖ ﺑﺎﻟﻤﺎدة اﻟﻤﺴﺮﻃﻨﺔ؛ هﺬﻩ اﻟﺘﻐﻴﺮات 
 و أﻋﺘﺒﺮت ﺗﻐﻴﺮات ﺳﺎﺑﻘﺔ ﻟﻠﺘﺴﺮﻃﻦ و ﻟﻢ ﻳﻼﺣﻆ وﺟѧﻮد ﺁﻓѧﺎت  بآﺎﻧﺖ اآﺜﺮ وﺿﻮﺣﺎ ﻓﻰ اﻟﻤﺠﻤﻮﻋﺔ 
ت اﻟﻜﺒﺪ  ﺑﻐѧﺮض اﻟﺘﻌѧﺮف ﻋﻠѧﻲ أﺟﺮي اﻟﻔﺤﺺ اﻟﻨﺴﻴﺠﻰ اﻟﻜﻴﻤﻴﺎﺋﻰ اﻟﻤﻨﺎﻋﻰ ﻟﻌﻴﻨﺎ . ﻧﺨﺮﻳﻪ أو اﻟﺘﻬﺎﺑﻴﺔ 
آѧﺎن . آﻌﻼﻣﺔ ﺗﺴﺮﻃﻦ، ﺑﺎﺳﺘﺨﺪام ﻃﺮﻳﻘﺔ ﻣﺮآﺐ اﻷﻓﻴﺪﻳﻦ ﺑﻴѧﻮﺗﻴﻦ ( P-TSG)اﻟﺒﺆر اﻻﻳﺠﺎﺑﻴﺔ ﻻﻧﺰﻳﻢ 
هﻨѧﺎك  اﻧﺨﻔﺎﺿѧًﺎ آﺒﻴѧﺮًا ﻓѧﻲ ﻋѧﺪد اﻟﺒѧﺆر اﻻﻳﺠﺎﺑﻴѧﺔ ﻟﻺﻧѧﺰﻳﻢ ﻓѧﻲ  ﺷѧﺮاﺋﺢ  اﻟﻜﺒѧﺪ ﻟﻤﺠﻤﻮﻋѧﺎت اﻻﺧﺘﺒѧﺎر 
ﺤﺒѧѧﺔ اﻟѧѧﺴﻮداء ﺗѧѧﺎﺛﻴﺮ ﻓѧѧﻲ ﺧﻠѧѧﺼﺖ اﻟﺪراﺳѧѧﺔ اﻟѧѧﻲ ٳن ﻟﻤѧѧﺴﺘﺨﻠﺺ اﻟ .  هو أ ﺧﺎﺻѧѧﺔ ﻓѧѧﻲ اﻟﻤﺠﻤѧѧﻮﻋﺘﻴﻦ 
اﻟﻮﻗﺎﻳﺔ ﺿﺪ اﻟﺘﺴﺮﻃﻦ اﻟﻜﺒﺪي اﻟﻤﺤﺪث ﺑﻤѧﺎدة ﺛﻨѧﺎﺋﻲ اﻳﺜﻴѧﻞ اﻟﻨﻴﺘѧﺮوزاﻣﻴﻦ ﻓѧﻲ اﻟﺠѧﺮذان إذا ﻣѧﺎ أﻋﻄѧﻰ 
.                              ﺑﻌﺪ ﺳﺎﻋﺎت ﻗﻠﻴﻠﺔ ﻣﻦ ﺣﻘﻦ اﻟﻤﺎدة اﻟﻤﺴﺮﻃﻨﺔ أو ﻋﻨﺪ ﺗﺠﺮﻳﻌﻪ ﻗﺒﻞ اﻟﻤﺎدة اﻟﻤﺴﺮﻃﻨﺔ ﺑﺴﺖ  أﺳﺎﺑﻴﻊ
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CHAPTER ONE  
 
INTRODUCTION 
      
Increased utilization of indigenous plant medicines in developing 
countries became a World Health Organization policy in the 1970s. There is 
evidence that the use of plants as medicines dates from the earliest years of 
man's evolution. People in widely separated cultures, with no obvious means 
of communication, are known to have used the same plants for similar 
medical problems (Fransworth, 1984). Almost 400 plant drugs were 
recorded in a Chinese herbal of 2800 BC and Hippocrates (460-377 BC) 
used about 400 drugs, most of which were derived from plants (Phillips, 
1992).                           
 Cancer has become an important topic in medicine since it is a major 
cause of death in both the developed and developing countries and it is now 
only secondary to myocardial infarction (Gruddy, 1991). A great majority of 
human cancers (about 80-90%) are attributable to environmental factors 
(Benjamin et al., 1990). However, it is not an easy task to eliminate 
carcinogenic causes from the environment. While modern surgery has 
significantly reduced cancer mortality, the use of additional treatment such 
as radiotherapy and chemotherapy has resulted in no more than 5% 
reduction in the number of deaths (Benjamin et al., 1990). Therefore, there 
is a continuing search for better control and preventive methods in order to 
reduce cancer mortality and related side effects. Many investigations are 
now being carried out to discover naturally occurring compounds, which can 
suppress or prevent the process of carcinogenesis (Wargovich et al.; 1988 
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and Thapliyal et al., 2002). One of these plants is the black seed (Nigella 
sativa) which has been used by Asian and Far Eastern countries as a spice, 
food preservative, and in traditional folk medicine for the treatment of 
numerous pathological disorders (Gali-Muhtasib and Schneider-Stock, 
2004). The seeds of this plant are very rich and diverse in chemical 
composition. Among the chemical components of black seed, thymoquinone 
(TQ) is the most abundant active principle and the most extensively 
investigated.     
The objectives of this study were to investigate: 
1-The protective effect of Nigella sativa (NS) against hepatocarcinogenesis 
given before or shortly after Diethylnitrosamine (DEN). 
2-The possible curative effect of NS given after injection of DEN.  
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Over the recent years, there has been growing interest in naturally 
occurring phytochemical compounds with anti-cancer potential, because 
they are relatively nontoxic, inexpensive and available in an ingestive form. 
More than 25% of the drugs used during the last 20 years are directly 
derived from plants, while the other 25% are chemically altered natural 
products (Vuorelaa et al., 2004). Black seed is one of the most extensively 
studied plants both phytochemically and pharmacologically. Numerous 
studies have shown that the seeds and the oil of this plant are characterized 
by a very low degree of toxicity (Ali and Blunden, 2003). 
The seeds of Nigella sativa, an annual Ranunculaceae herbaceous 
plant, have been used traditionally for centuries in the Middle East, Northern 
Africa and India for the treatment of asthma, cough, bronchitis, headache, 
rheumatism, fever, influenza, eczema, as a diuretic, lactagogue and 
vermifuge; Furthermore, black cumin (N. sativa) seeds are of importance as 
a carminative and spice, often used as a condiment in bread and other dishes 
(Lautenbacher, 1997; Merfort et al., 1997; Eschborn, 1997 and Aboutabl et 
al., 1986). Traditionally, there is a common islamic belief that the ‘black 
seed, is a panacea (universal healer) that is a remedy for all ailments, but 
cannot prevent death (Hadeeth). In the bible, N. sativa is also identified as 
‘curative black cumin’, and is also described as the Melanthion of 
Hippocrates and Dioscorides and as the Gith of Pliny (Worthen et al., 1998). 
These seeds, in Arabia are known as ‘Habbah Sauda’, ‘Habbet el Baraka’, 
‘Kamun-aswad’ and ‘Shunez’ (Houghton et al., 1995). 
 The seeds contain 36%–38% fixed oils, proteins, alkaloids, saponin 
and 0.4%–2.5% essential oil (Lautenbucher, 1997). The fixed oil is 
composed mainly of unsaturated fatty acids, including the unusual C20:2 
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arachidic and eicosadienoic acids (Houghton et al., 1995). The essential oil 
was analyzed by Burits and Bucar (2000) and many components were 
characterized, but the major ones were thymoquinone (27.8%–57.0%), ρ-
cymene (7.1%–15.5%), carvacrol (5.8%–11.6%), t-anethole (0.25%–2.3%), 
4-terpineol (2.0%–6.6%) and longifoline (1.0%–8.0%). Thymoquinone 
readily dimerizes to form dithymoquinone (El-Dakhakhny, 1963). 
 Four alkaloids have been reported as constituents of   the seeds. Two, 
nigellicine and nigellidine have an indazole nucleus, whereas nigellimine 
and its N-oxide are isoquinolines (Atta-ur-Rahman b et al., 1985; Atta-ur-
Rahman et al., 1995; Atta-ur-Rahman et al., 1992 and Atta-ur-Rahman a et 
al ., 1985). 
 Thymoquinone, TQ, is the bioactive constituent of the volatile oil of 
black seed and was first extracted by (El-Dakhakhany, 1963). It has been 
shown to exert anti-inflammatory, anti-oxidant and anti-neoplastic effects 
both in vitro and in vivo. The active lipid soluble compound TQ can be 
found only in a crystalline triclinic form as determined by high resolution X-
ray powder diffraction (Pagola et al., 2004). Several methods have been 
used to quantify the levels of TQ in black seed oil, such as gas 
chromatography (Houghton et al., 1995), high performance liquid 
chromatography (Ghosheh et al., 1999) and differential pulse polarography 
(Michelitsch and Rittmannsberger, 2003). TQ is not the only bioactive 
constituent of black seed oil; other pharmacologically active constituents 
could be identified by HPLC, include dithymoquinone, thymohydroquinone 
and thymol (Ghosheh et al., 1999). Other fractionated proteins of N. sativa 
ranging in their molecular mass from 10 to 94 KDa were purified by ion 
exchange chromatography and have also been found to be bioactive (Haq et 
al., 1999). 
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Nigella  sativa seeds and its constituents appear to have a low level of 
toxicity. Administration of seed extract (50 mg/kg) intraperitoneally to rats 
for 5 days did not significantly affect the activities of several enzymes and 
metabolites indicative of hepatic and renal function (El Daly, 1998). Also 
oral administration of the seed oil at doses up to 10 ml/kg in rats and mice 
did not cause any mortality or overt toxicity during an observation period of 
48 h (Khanna et al., 1993). It was also shown that oral administration of the 
fixed oil of N. sativa at a dose of 10 ml/kg, for up to 12 weeks did not cause 
any mortality or significant alteration of the key hepatic enzymes in rats 
(Zaoui b et al., 2002). The LD50 value of thymoquinone was found to be 2.4 
g/kg (range 1.52–3.77) (Badary et al., 1998). Acute administration of high 
doses of TQ (2 g/kg or more) caused hypoactivity and difficulty in 
respiration while, inclusion of thymoquinone in the drinking water for mice 
at concentrations of up to 0.03% for 90 days resulted in no signs of toxicity, 
except for a significant decrease in fasting plasma glucose concentration 
(Badary et al., 1998). 
 
2. 2. ROLE IN ISALMIC CULTURE 
 Seeds of N. sativa have been used almost in different Islamic 
countries in Middle East, Northern Africa and India for the treatment 
different diseases such as asthma, cough, bronchitis, headache, rheumatism, 
fever, influenza, eczema, as a diuretic, lactagogue and vermifuge. Using of 
thses seeds is related to the Islamic believe that N. sativa was mentioned in 
Sahih Elbukhari as a panacea (universal healer) that is a remedy for all 
ailments, but cannot prevent death (Hadeeth). 
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2. 3. GENERAL USE OF NIGELLA SATIVA AND THYMOQUINONE 
Many of the claimed folk medicinal uses of this plant have been 
scientifically tested. Studies have been conducted, particularly during the 
past two decades, on the effect of N. sativa seed extract or its active 
compounds (thymoquinone, the main compound of the essential oil) on 
various body systems in vivo or in vitro. 
It has been shown that both the fixed oil of N. sativa, as well as 
thymoquinone inhibit non enzymatic lipid peroxidation in liposomes 
(Houghton et al., 1995). Using thin-layer chromatography (TLC), it has also 
been shown that compounds isolated from N.sativa including thymoquinone, 
carvacol, t-anethole and 4-terpineol have appreciable free radical scavenging 
properties (Burtis and Bucar, 2000). These compounds were found in a 
series of other in vitro tests to have variable antioxidant, but no prooxidant 
properties. The different compounds in the oil were found to act in a 
synergistic manner. This stresses the importance of using the whole oil or 
the crude extract of the seeds in pharmacological studies. Although the 
antioxidant property of N. sativa is multifactorial, it does not seem to 
involve iron-complexing activity (Burtis and Bucar, 2000). Generation of 
free radicals may be, at least partially, the basis of many human diseases and 
pathological conditions. Therefore, the antioxidant action of N. sativa may 
explain its claimed usefulness in folk medicine. This antioxidant property 
would explain its action against CCl 4 hepatotoxicity (Nagi et al., 1999), 
liver fibrosis and cirrhosis (Türkdogan et al., 2000) and hepatic damage 
induced by Schistosoma mansoni infection (Mahmoud et al., 2002). 
Khanna et al. (1993), using three antinociceptive tests in rats and 
mice, concluded that the fixed oil of the seeds is endowed with strong 
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antinociceptive actions, and that these actions were due to an opioid 
principle in the oil, as they were antagonized by naloxone.  
Aqueous extract of N. sativa seeds was tested for its anti-
inflammatory, analgesic and antipyretic action in mice (Al-Ghamdi, 2001), 
using carrageenan-induced paw oedema as a model of inflammation, and the 
hot plate reaction time as a model of nociception. The extract was found to 
possess significant anti-inflammatory and analgesic action, but it failed to 
alleviate yeast-induced pyrexia. This finding lends some credence to the folk 
medicinal use of the plant as an anti-inflammatory and analgesic substance, 
and also confirms previous reports on the antinociceptive (Abdel-Fattah et 
al., 2000) and anti-inflammatory effects of N. sativa oil and its major 
component, thymoquinone, in mice (Mutabagani and El-Mahdi, 1997). The 
possible mechanism by which N. sativa exerts its antiinflammatory action 
has been studied. Thymoquinone has been shown to be a potent inhibitor of 
eicosanoid generation, namely thromboxane B2 and leucotrienes B4, by 
inhibiting both cyclooxygenase and lipooxygenase, respectively (Houghton 
et al., 1995). Interestingly, it was found that the fixed oil of N. sativa had 
both antioxidant and anti-eicosanoid effects greater than thymoquinone, 
which is its active constituent (Houghton et al., 1995). 
El-Dakhakhny et al., (2000) has shown that pretreatment of rats with 
N. sativa oil for 4 weeks was effective in protecting against carbon 
tetrachloride and D-galactosamine-induced hepatic damage. The protection 
against the former hepatotoxicity was partial, while that of the latter was 
complete. No ill effects on liver function were observed when the oil was 
given orally at a dose of 800 mg/kg/day for 4 weeks. The oil was also found 
to reduce significantly serum total cholesterol, low-density lipoproteins and 
triglycerides and also high-density lipoproteins. In rabbits, experimental 
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liver cirrhosis and fibrosis (induced by carbon tetrachloride) was shown to 
be prevented by the prior administration of N. sativa. In mice, thymoquinone 
at dose of 8 mg/ kg/day for 5 days before and 1 day after carbon 
tetrachloride was found to protect against the biochemical and histological 
markers of liver damage (Al-Gharably et al., 1997). The protection was 
suggested to be related to the ability of thymoquinone to inhibit lipid 
peroxidation 
 
2. 4. ANTI CANCER ACTIVITY OF NIGELLA SATIVA AND 
THYMOQUINONE  
Several workers have investigated the possible antitumour activity of 
some crude and purified components of N. sativa. Salomi et al. (1992) have 
shown that a crude methanol extract of the seeds exhibited a strong cytotoxic 
action on Erlich ascites carcinoma, Dalton’s ascites lymphoma and sarcoma 
cells, while exerting minimal cytotoxicity to normal lymphocytes. The same 
authors confirmed the cytotoxic property of the seeds in vivo by inhibiting 
the growth of Erlich ascites carcinoma in mice receiving 2 mg of the extract 
/ day for 10 days (Salomi a et al., 1992). In another study the anticancer 
activity of N.sativa was also reported against malignant cells in mice 
(Salomi et al., 1991 and in humans (Salomi b et al., 1992 and Worthen et al., 
1998). A dose of 100 mg/kg body weight of N. sativa extract delayed the 
onset of papilloma formation and reduced the mean number of papillomas 
(Salomi et al., 1991; Worthen et al., 1998). It has also been shown that 
exposure to the volatile oil of N. sativa altered the cellular expression of 
specific polypeptides in Jukart T lymphoma cells, suggesting that changes in 
polypeptide expression might play a role in the biological activities 
attributed to N. sativa (Hailat et al., 1995). 
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Strong in vitro cytotoxic action of the ethylacetate fraction of N. 
sativa seed extract against different classes of cancer cell lines has been 
reported (Swamy and Tan, 2000). In vivo and in vitro inhibitory effects of 
TQ against 20-methylcholanthrene (MC)-induced fibrosarcoma (Badary and 
Gamal, 2001) and against benzo(a)pyrene-induced forestomach 
carcinogenesis (Badary et al., 1999) were reported in mice. The incidence 
and multiplicity of the fibrosarcoma was significantly inhibited by about 
43% and 34%, respectively, and the forestomach cancer by 70% and 67%, 
respectively, when thymoquinone was administered (0.01% in the drinking 
water) one week before and after MC treatment. The onset of fibrosarcoma 
and incidence of mortality were both delayed by the treatment. It has also 
been shown that TQ was effective in inhibiting the survival of the 
fibrosarcoma in vitro. 
 Kumara and Huat (2001), isolated a principle component from the 
seeds of N. sativa, termed alpha-hederin that has strong in vivo antitumour 
activity in mice implanted with Lewis lung sarcoma and murine P388 
leukaemia. 
A decoction comprized of N. sativa (seeds), Hemidesmus indicus 
(root) and Smilax glabra (rhizome) was used to treat rats against DEN 
induced hepatocacinogenses in rats. Traditionally, all the three plant types 
used in the formulation of this decoction are considered useful in the 
preparation of medications used in the treatment of boils and other skin 
conditions (Perera DL and de Silva G., 2002). Investigations have been 
initiated to determine the ability of the above decoction to protect against 
DEN-induced hepatocarcinogenesis. The overall results of the study, 
indicated that the decoction has the potential to protect rat liver against DEN 
induced hepetocarcinogenesis. (Iddamaldeniya et al., 2003). 
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Several studies have shown that TQ retards the carcinogenic process 
in animals. TQ was found to inhibit tumor formation in DMBA-initiated 
TPA-promoted mouse skin tumor (Salomi et al., 1991). The protective 
actions of TQ have been suggested to be through its antioxidant and anti-
inflammatory activities (Nagi and Mansour, 2000). Which could be 
demonstrated in animal models and cell culture systems (Mansour et al., 
2002).                                            
The tumor suppressor p53 is the most commonly mutated gene in 
human cancers (Soussi, 1996). Cells can respond to the activation of the 
tumor suppressor protein p53 by undergoing cell-cycle arrest or apoptosis 
(Levine, 1997). Active p53 is able to stimulate the transcription of a variety 
of genes including p21WAF1, which is a universal inhibitor of the cyclin-
dependent kinases (CDK) (Kagawa et al., 1997; Kokontis et al., 2001). 
P21WAF1 overexpression is thought to be a major mediator of p53- dependent 
G1 arrest, is required to arrest cells at the G1 and G2 checkpoints of the cell 
cycle after DNA damage (Han et al.,  2002 and Niculescu et al., 1998) and is 
associated with a reduction of cyclin B1 expression (Medema et al., 1998). 
In contrast to p21WAF1, the overexpression of Bcl-2 protein has been shown 
to inhibit p53- mediated apoptosis as well as p53-mediated transcriptional 
activation (Shen and White, 2001). In addition, p16INK4a, a recognized tumor 
suppressor, induces G1 cell-cycle arrest by binding to CDK4, and inhibiting 
its ability to interact with cyclin D and stimulate passage through the G1 
phase of the cell cycle. A study shows that treatment of neoplastic 
keratinocytes with TQ remarkably inhibits their proliferation at 
concentrations non-cytotoxic to primary mouse keratinocytes; Interestingly, 
the SP-1 papilloma cell line was more sensitive to the growth inhibitory 
effects of TQ, suggesting that the sensitivity to TQ treatment is dependent on 
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the stage of tumorigenesis. Cell growth inhibition achieved by TQ treatment 
was correlated with G1 and G2 phase arrest of the cell cycle followed by 
apoptosis; This finding support a potential role for TQ as a skin 
antineoplastic agent, especially at the early tumorigenesis stages. Many 
investigators have shown that the growth inhibitory effects of TQ are 
specific to cancer cells (Gali-Muhtasib a et al., 2004; Gali-Muhtasib b et al., 
2004; Shoieb et al., 2003 and Worthen et al., 1998). TQ showed significant 
anti-neoplastic activity against human pancreatic adenocarcinoma, uterine 
sarcoma and leukemic cell lines, while it is minimally toxic to normal cells 
(Worthen et al., 1998). 
The multidrug-resistant variants of human pancreatic  adenocarcinoma, 
uterine sarcoma and leukemic cell lines, which are over 10-fold more 
resistant to the standard anti-neoplastic agents doxorubicin and etoposide as 
compared to their respective parental controls, were equally sensitive to TQ 
(Worthen et al., 1998). The induction of apoptosis in tumor cells is a key 
mechanism for the effectiveness of chemopreventive drugs. TQ has been 
shown to induce apoptosis by p53-dependent (Gali-Muhtasib b et al., 2004) 
and p53-independent (El-Mahdy et al., 2005) pathways. In HCT-116 human 
colon cancer cells, the pro-apoptotic effects of TQ are dependent on p53 
(Gali-Muhtasib b et al., 2004), while in myeloblastic leukemia HL-60 cells, 
TQ-induced apoptosis is p53-independent and occurs through the activation 
of caspase 8, 9 and 3 (El-Mahdy et al., 2005). TQ treatment of HCT-116 
cells resulted in a marked increase in p53 and p21 protein levels and in a 
significant inhibition of the anti-apoptotic Bcl-2 protein (Gali-Muhtasib b et 
al., 2004). Co-incubation with the specific p53-inhibitor, pifithrin-alpha, 
restored the mRNA and protein levels of Bcl-2, p53 and p21 to control 
levels and suppressed TQ-induced apoptosis. P53-null HCT-116 cells are 
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less sensitive to TQ-induced apoptosis (Gali- Muhtasib b et al., 2004). 
Furthermore, TQ induces apoptosis in osteosarcoma cells (Shoieb et al., 
2003) and neoplastic keratinocytes (Gali-Muhtasib a, et al., 2004). By 
contrast, normal cells and primary mouse keratinocytes are resistant to the 
apoptotic effects of TQ (Shoieb et al., 2003; Gali-Muhtasib a, et al. 2004) 
and no significant alteration of their morphology and proliferation is 
observed, confirming the selectivity of this compound to cancer cells (Gali-
Muhtasib a et al., 2004).                                                                                                              
Growth inhibition by TQ is associated with inhibition of DNA synthesis 
(Worthen et al., 1998) and induction of cell cycle arrest (Shoieb et al., 
2003). The mechanism of anti-proliferation in papilloma cells was triggered 
by the induction of G1 cell cycle arrest and the restoration of p16 protein 
levels. Treatment of mouse papilloma cells with 30 µM TQ caused a 22% 
increase in the number of cells in the G1 phase within 24 h. TQ-induced G1 
arrest was associated with sharp increases, from null to 10- fold, in p16 
protein levels as early as 2h after treatment, and this increase was sustained 
for up to 24 h (Gali-Muhtasib a et al., 2004). The latter is of special interest 
considering the fact that the modulation of p16 expression increases tumor 
sensitivity to chemotherapeutic drugs (Hochhauser, 1997). On the other 
hand, TQ treatment of the more aggressive mouse spindle cancer cells 
caused G2/M arrest (38% increase), which was accompanied by decrease in 
cyclin B1 protein expression (Gali-Muhtasib a et al., 2004). Recent, 
investigations have shown that TQ suppresses the proliferation of several 
human colon cancer cell lines, including Caco-2, LoVo, HT-29, DLD-1 and 
HCT-116 cells (Gali-Muhtasib et al., unpublished findings). Growth 
inhibition of HCT-116 human colon cancer cells by TQ correlated with G1 
phase arrest of the cell cycle (Gali-Muhtasib b et al., 2004). A significant 
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up-regulation of p53 and p21 transcript and protein levels, as well as a 
significant decrease in Bcl-2, in TQ-treated cells has been noted. In another 
study, TQ-induced growth inhibition and cell cycle regulation were 
examined in cisplatin-sensitive and cisplatin-resistant canine osteosarcoma 
cells (Shoieb et al., 2003). TQ was four- to five-fold more cytotoxic to the 
resistant cell line than its correspondent parent line. It is noteworthy that 
cisplatin-resistant osteosarcoma cells are seven- to eight-fold more resistant 
to the cytotoxic effects of cisplatin compared to the parental cell line. TQ-
induced death of cisplatin-sensitive osteosarcoma cells was due to cell cycle 
arrest at G1 phase as determined by flow cytometry analysis. Treatment with 
50µM TQ for 24 h resulted in three-fold increase in the percentage of cells 
in G1 as compared to control (Shoieb et al., 2003). 
 
2. 5. EFFECTS OF NIGELLA STIVA AND THYMOQUINONE ON 
CANCER DRUGS 
 N. sativa and its conistituents not only have  anti-cancer effects, but 
also have the ability to attenuate the side effects of cancer drugs  and to 
enhance their anti tumor activity. 
N. sativa seeds or it`s compounds have been shown to prevent cancer 
and / or to reduce the cytotoxicity of standard antineoplastic drugs. It has 
been shown that topical application of N. sativa extract inhibited the two-
stage initiation and promotion of skin cancer by dimethylbenzo[a] 
anthracenecroton oil in mice and that intraperitoneal injections of the same 
N. sativa extract reduced by about 67% the incidence of soft tissue sarcomas 
seen after 30 days of subcutaneous 20 methylcholanthrene (MCA) injections 
(Salomi et al., 1991).  In another study, Nair et al. (1991) showed that 
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treatment with a crude ethanol extract of N. sativa  significantly reduced 
cisplatin induced mice. 
Ifosfamide (IFO) is a cyclophosphamide analogue, which belongs to a 
class of anticancer drugs known as oxazaphosphorine nitrogen mustards 
(Brade et al., 1986). IFO is active against a variety of human malignancies 
(Brade et al., 1991; Rosen et al., 1994), however, nephrotoxicity is a major 
hazard of clinical treatment (English et al., 1997; Tokuc et al., 1997). Renal 
toxicities of IFO include Fanconi syndrome (FS), proteinuria, renal tubular 
defects, reductions in glomerular filtration rate (GFR) and, uncommonly, 
acute renal failure (Rossi et al., 1994; Berns et al., 1995). Renal FS is 
characterized by a generalized disorder in proximal tubule transport and is 
associated with a number of disease states ranging from inherited disorders 
of metabolism to injury resulting from exposure to exogenous toxins 
(Foreman et al., 1995; Nissim and Weinberg, 1996) including IFO 
chemotherapy (Pratt et al., 1991). TQ when given in drinking water (5 
mg/kg/day) for 5 days before and 5 days after concomitantly with ifosfamide 
(IFO) has been shown to attenuate significantly the renal toxicity of IFO 
(Fanconi syndrome) and to enhance its antitumour activity in mice (Badary, 
1999). The antioxidant action of TQ has been suggested as the mechanism 
by which the nephrotoxicity of IFO is mitigated, and this is reminiscent of 
the reported protective action of TQ on cisplatin nephrotoxicity in mice and 
rats (Badary et al., 1997). The latter workers have also shown that TQ 
enhances the antitumour activity of cisplatin. Worthen et al. (1998) have 
tested in vitro a crude gum, a fixed oil and two purified components of the 
seed [TQ and DIM] for their cytotoxicity to several parental and multi-drug 
resistant (MDR) human tumour cell lines. The gum and the oil (up to 1% 
w/v) were devoid of cytotoxicity, while both TQ and DIM were both 
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cytotoxic to all of the cell lines. Both the parental cell lines and their 
corresponding MDR variants (that were resistant to several standard 
antineoplastic drugs) were equally sensitive to TQ and DIM. The action of 
the latter components as cytotoxic agents was found not to be related to 
generation of free radicals. 
Administration of N. sativa seed extract (50 mg/kg) 30 min before the 
administration of the nephrotoxic drug cisplatin was effective in 
ameliorating the biochemical and physiological indices of nephrotoxicity (El 
Daly, 1998). This was in confirmation of an earlier report (Badary et al., 
1997) that TQ attenuates the nephrotoxicity of cisplatin and enhances its 
antitumour activity. The reason for the protective action is not certain, but 
may be related to the antioxidant action of the extract, and the fact that the 
nephrotoxic drug may induce its effect via generation of free radicals. 
The combination of TQ with clinically used anti-cancer drugs, such as 
isofosfamide, cisplatin and doxorubicin, has led to improvements in their 
therapeutic index and to the protection of non-tumor tissues against 
chemotherapy induced damage. Administration of TQ in drinking water 
resulted in powerful chemopreventive effects on benzo(a)pyreneinduced 
stomach tumors (Badary, et al., 1999). Tumor incidence and multiplicity 
were inhibited by 70% and 67%, respectively. In the methylcholanthrene-
induced tumor model, the administration of TQ in drinking water 
significantly decreased the number of mice with fibrosarcomas and the 
number of tumors by 34%. Furthermore, drug-induced mortality was 
lowered (Badary and Gamal, 2001). TQ reduced isfosfamide-induced 
Fanconi syndrome in rats and enhanced its anti-tumor activity in Ehrlich 
ascites carcinoma-bearing mice (Badary, 1999). In this model, TQ protected 
the kidney against isfosfamide-induced damage by preventing renal 
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glutathione depletion and lipid peroxide accumulation. Furthermore, mice 
treated with isfosfamide in combination with TQ showed a slighter body 
weight loss and a lower mortality rate compared to single therapy. 
Furthermore, TQ averted carbon tetrachloride-induced hepatotoxicity 
in mice (Mansour, 2000). A single injection of carbon tetrachloride results in 
acute liver injury and significant elevation of activities of serum enzymes. 
Pretreatment of mice with TQ in drinking water reduced the elevated levels 
of serum enzymes, reduced hepatic lipid peroxidation and significantly 
increased the sulfhydryl content of hepatic tissues (Al-Gharably et al., 1997; 
Mansour, 2000). In other studies, TQ inhibited the toxicity induced by 
doxorubicin, an anti cancer compound that causes toxicity to heart tissues 
due to the generation of superoxide free-radical (Al-Shabanah et al., 1998; 
Nagi and Mansour, 2000). Oral administration of TQ in drinking water 
before a single injection of doxorubicin ameliorated drug-induced 
cardiotoxicity in rats (Nagi & Mansour, 2000). TQ exerts protective effects 
on doxorubicin damage mainly due to its superoxide-scavenging and anti-
lipid peroxidation effects. TQ also avoided the nephropathy and oxidative 
stress induced by doxorubicin in rats (Badary et al., 2000). Nephropathy is 
associated with high urinary excretion of protein and albumin, and these 
effects were significantly suppressed by treating rats with TQ administered 
in drinking water (Badary et al., 2000). 
  
2. 6. MOLECULAR PATHWAY OF THYMOQUINONE  
There has been intense efforts not only on identifying new 
chemotherapeutic and chemopreventive agents but also on understanding 
how the existing agents exhibit their activities. The inhibitory effects of TQ 
on chemically induced carcinogenesis have been recognized. For example, 
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TQ inhibited 20 methylcholantherene-induced fibrosarcoma (Badary and 
Gamal El-Din, 2001), benzo[a]pyrene-induced forestomach carcinogenesis 
(Badary et al., 1999) and tumor formation in DMBA-initiated, TPA-
promoted mouse skin (Salomi et al., 1991). Additionally, a potential role has 
been reported for TQ as a chemopreventive agent at the early stage of skin 
tumorigenesis (Gali-Muhtasib a et al., 2004). The antineoplastic activity of 
TQ may be attributed to its inhibitory effects on cancer cell growth and its 
capability of inducing apoptosis in cancer cells (Gali-Muhtasib a et al., 
2004). Apoptotic cell death is characterized by chromatin condensation and 
apoptotic bodies. (Chen et al., 1998 and Chen et al., 2002). Signaling for 
apoptosis occurs through multiple pathways, initiated by diverse 
extracellular and intracellular signals (Strasser et al., 2000). A family of 
cysteine proteases, known as caspases, plays a pivotal role in the regulation 
and execution of apoptotic cell death. When caspases are activated, they 
cleave a number of key substrates, resulting in their activation or 
inactivation. These key substrates orchestrate the morphologic and 
biochemical features of apoptosis (Bossy-Wetzel and Green 1999). Two 
pathways of caspase activation have been established for propagating death 
signals (Gewies et al., 2000 and Budihardjo et al., 1999). The first is 
mediated by death receptors, such as Fas and TNF receptors (Nagata, 1997). 
When Fas ligand binds to Fas receptor, this recognition event is translated 
into intracellular signals that eventually lead to activation of caspase-8 and 
other caspases (Budihardjo et al., 1999). Once caspase-8 is activated, it 
processes the effecter caspases, such as caspases 3, 6 and 7, inducing a 
cascade of caspases. The second pathway involves diverse proapoptotic 
signals originating inside the cell and converging at the mitochondrial level. 
(Bossy-Wetzel et al., 1998). Signals such as DNA damage, oxidative stress, 
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serum starvation as well as those induced by chemotherapeutic drugs 
provoke release of cytochrome C and other proapoptotic proteins from the 
mitochondrial intermembrane space into the cytoplasm, leading to activation 
of apoptosome, then caspase-9 and its downstream caspases. (Kaufmann and 
Earnshaw, 2000; Wang, 2001). The central role of mitochondria in apoptosis 
has been established. It is known that the antiapoptotic protein Bcl2 localizes 
in the outer membrane of mitochondria. (Nguyen et al., 1993). Mitochondria 
amplify and mediate extrinsic apoptotic pathways and play a central role in 
integrating and propagating death signals inside the cell. Most apoptosis 
inducing stimuli involve disruption of the mitochondrial inner 
transmembrane potential as well as the permeability transition, resulting in 
release of the proapoptotic proteins from the mitochondrial intermembrane 
space into the cytoplasm (Bernardi et al., 1999; Loeffler and Kroemer, 
2000). TQ induces apoptosis in many different human tumor cells, such as 
neoplastic keratinocytes, colorectal cancer cells, breast adenocarcinoma and 
ovarian adenocarcinoma cells (Nguyen et al., 1993;  Shoieb et al., 2003). 
Gali-Muhtasib b et al. (2004) found that TQ triggers apoptosis via a 
p53-dependent mechanism in HCT116 human colorectal cancer cells. 
However, p53 function is compromised in many human cancers (Hollstein a 
et al., 1994; Hollstein et al., 1991). To understand the pathways through 
which TQ exerts its apoptotic effects, an experiment examined the effect of 
TQ on the activation of initiator and effecter caspases in p53-null HL-60 
cells. The evidence that TQ-induced, p53- independent apoptosis in HL-60 
cancer cells is mediated via a pathway which triggers the activation of a 
caspase cascade has been provided. Caspase-8 works upstream of caspase-3 
and provokes the translocation of cytochrome C from the mitochondrial to 
the cytosolic compartment of HL-60 during TQ-induced apoptosis. 
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2. 7. ANTI MICROBIAL EFFECT OF NIGELLA SATIVA 
A number of reports have been published on the effects of N. sativa 
extracts or its oil on different bacterial isolates. The extract and the oil have 
been reported to have a broad spectrum of activity against a number of 
microbes. For example, in vitro antibacterial effects of the essential oil 
showed pronounced activity even in 1:100 dilutions against several 
organisms that included Staphylococcus albus, Escherichia coli, Salmonella 
typhi, Shigella niger and Vibrio cholera (Agrawal et al., 1979). Generally  
the oil was more effective against Gram-positive than Gram-negative 
organisms. The oil was also found to have excellent antifungal activity, 
particularly against Aspergillus species (Agrawal et al., 1979). Among 
others, El-Kamali et al. (1998), confirmed the above report and showed that 
the essential oil of N. sativa  was effective against Gram-positive 
(Staphylococcus aureus and Bacillus subtilis) and Gram-negative bacteria 
(Escherichia coli and Pseudomonas aeruginosa). The antibacterial effect 
was maximal when Bacillus subtilis was used. It was noted that Gram-
negative were affected more than Gram-positive isolates and that, like some 
antimicrobial agents, the extracts exerted more antibacterial action at lower 
than higher concentrations. Physicochemical factors (solubility and 
diffusion) may account for this effect. Nigella  sativa oil, given 
intraperitoneally, has been shown to exhibit a potent action against murine 
cytomegalovirus infection in mice. The action was suggested to be related to 
the potentiating action of the oil on innate immunity (Salem and Hossain, 
2000). 
The antimicrobial activity of N. sativa was further confirmed against 
several species of pathogenic bacteria and pathogenic yeasts (Candida 
albicans) (Hanafy and Hatem, 1991). 
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2. 8. ANTI PARASITIC EFFECT OF NIGELLA SATIVA 
Nigella sativa oil has been shown to possess anticestodal and 
antinematodal properties comparable to those of piperazine (Agrawal et al., 
1979). Administration of N. sativa oil concomitantly with praziquantel 
lowered further the number of dead ova than was observed when 
praziquantel was given alone, indicating that the plant oil potentiates the 
action of praziquantel. The active components of the black seed were studied 
against several nematodes and cestodes (Akhtar and Riffat, 1991). The effect 
of the black seed has also been evaluated in clinical studies and animal one 
(Mahfouz et al., 1962; Salomi and Panikkar, 1989; Nair et al., 1991 and  
Tennekoon et al., 1991).  
 
2. 9. IMMUNE RESPONSE INDUCED BY NIGELLA SATIVA 
Oxidative stress and inflammatory disorders are now widely known as 
the major pathogenetic factors of carcinogenic malignant transformation 
(Coussens and Werb, 2002). Several studies point to the effect of black seed 
(N.sativa) and TQ on the immune system by modulating the levels of pro- 
and anti-inflammatory mediators (Badary, et al., 2003). TQ has also been 
shown to inhibit inflammation and oxidative stress in cells (Houghton et al., 
1995 and Mansour et al., 2002). The anti-inflammatory effect of black seed 
has been found to be comparable to that of 100 mg/kg aspirin (Al- Ghamdi, 
2001). The seeds produce an increase in the ratio of helper to suppressor T 
cells and enhance natural killer cell activity in healthy volunteers (El-Kadi, 
et al., 1989). A recent study has shown that the intraperitoneal injection of 
black seed essential oil leads to significant anti-inflammatory activities 
against carrageenan induced paw edema in rats (Hajhashemi et al., 2004). 
These immuno-potentiating effects may be mainly due to the TQ 
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component. In vitro studies have shown that TQ is a potent inhibitor of the 
eicosanoid generation, namely thromboxane B2 and leucotriene B4. It 
inhibits both cyclooxygenase and 5-lipoxygenase pathways of the 
arachidonate metabolism in rat peritoneal leukocytes (Houghton et al., 
1995). Using a COX- 2 assay, it has been shown that TQ (IC50 = 0.3µM) is 
an inhibitor that is more potent than indomethacin (IC50 = 0.6µM) of COX-
2-catalyzed PGE2 production (Marsik et al., 2005). TQ treatment 
completely averted the acetic acid induced colitis in rats (Mahgoub, 2003). It 
has also been reported to inhibit TNF-α production in murine septic 
peritonitis (Haq et al., 1999). Furthermore, TQ was found to reduce the 
nitric oxide (NO) production in supernatants of lipopolysaccharide (LPS)-
stimulated macrophages, without affecting their cell viability (El- 
Mahmoudy et al., 2002). The inducible NO synthase (iNOS) is responsible 
for the production of NO. El-Mahmoudy et al. (2002) found that, LPS-
stimulated macrophages showed decreased mRNA and protein expression 
levels of iNOS, as well as decreased immunofluorescence staining of this 
enzyme, when treated with TQ. In other studies, TQ has been reported to 
have potent superoxide anion (O2−) scavenging abilities and to inhibit iron 
dependent microsomal lipid peroxidation. The generation of superoxide 
anion by the xanthine/xanthine oxidase system was inhibited by TQ in a 
dose-dependent manner (IC50 = 3.4µM). This is promising considering the 
fact that (O2−) reacts with protein and non-protein sulfhydryls and 
polyunsaturated fats and initiates aromatic hydroxylation reactions, thus 
damaging cells and causing inflammation. Because free radical oxidative 
stress is implicated in many inflammatory diseases, it is logical that the anti-
inflammatory activities of TQ are attributed to its anti-oxidant effects. 
Because TQ has dual anti-oxidant and antiinflammatory activities, it may be 
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an agent which not only prevents the direct injurious effects of oxidants, but 
it may fundamentally alter the underlying inflammatory processes that play 
an important role in the pathogenesis of inflammatory bowel disease and 
colorectal cancer (Badary et al., 2003). 
 El-Kadi at al., (1987) were probably the first to show that N. sativa 
seeds have immunopotentiating properties in human T cells in vitro. This 
was confirmed by Haq et al., (1995), who showed that N. sativa seeds 
activate T-lymphocytes to secrete the interleukin, IL-3, and increase IL-1β 
production indicating a stimulatory effect on macrophages either through 
adirect effect or via IL-1β. In further experiments the same authors purified 
the proteins in the whole N. sativa seeds, and showed that some proteins 
have suppressive and others stimulatory properties in lymphocyte cultures 
(Haq et al., 1999). The proteins were also effective in the production of 
cytokines (e.g. IL-1β). Their results were some what different from that of 
(Swamy and Tan 2000) who reported that, using mouse spleenocytes, N. 
sativa extract, per se, has no immunomodulatory activity. In the presence of 
optimal doses of mitogen, however, there was a significant potentiation of 
the immune response, the mechanism of which is unclear (Swamy and Tan, 
2000). 
 
2. 10. BALANCE OF NUTRIENTS BY NIGELLA SATIVA 
Meral et al.  (2001) investigated the influence of N .sativa extract on 
lipid peroxides and glutathione, ceruloplasmin and glucose, as well as the 
histology of the liver and pancreas in diabetic rabbits. The results indicated 
that treatment with the extract for 2 months significantly reduced the 
elevated   concentration of glucose and lipid peroxides, and decreased that of 
glutathione and ceruloplasmin, and ameliorated the biochemical and 
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histological signs of liver damage. It was postulated that the basis of the 
beneficial effect of N. sativa in diabetes might be its antioxidant property. 
These results were in contrast to earlier reports from Kuwait, which seem to 
suggest that N. sativa seeds had no effect on streptozotocin-induced diabetes 
in rats (Al-Awadi and  Gumaa, 1987). It has been reported, though, that a 
mixture of five plants (including N. sativa) is commonly used by Kuwaiti 
diabetics to aid in the control of hyperglycaemia. The plant mixture was 
experimentally found to improve glucose tolerance in both streptozotocin 
diabetic and normal rats (Al-Awadi and Gumaa, 1987; Al-Awadi et al., 
1991). 
 
2. 11. CIRCULATORY DISORDERS AND NIGELLA SATIVA 
The actions of the volatile oil of N. sativa and TQ on the arterial blood 
pressure and heart of anaesthetized rats has been investigated by El-Tahir et 
al., (1993). Both agents, when injected intravenously, in dose dependently 
decreased arterial blood pressure and heart rate. It was concluded that 
cardiovascular actions of these agents are multifactorial, and are mediated 
mainly centrally via direct and indirect mechanisms that involve (among 
others) tryptaminergic and cholinergic mechanisms. Workers in Morocco 
have found that the dichloromethane extract of N. sativa seeds is endowed 
with strong diuretic and antihypertensive actions in spontaneously 
hypertensive rats (Zaoui et al., 2000). Recently, Zaoui (2002a) reported that 
the oral treatment of rats with the fixed oil of N. sativa 
(1ml/kg/day/12weeks) decreased serum cholesterol, triglyceride and glucose 
levels, and leucocyte and platelet counts by about 15–35%, compared to 
control values. The Hb and PCV levels were significantly increased by 6–
17%, respectively. These results indicate a possible beneficial effect of the 
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oil in hyperglycaemia and hyperlipidema, and probably as an adjunct to the 
treatment of certain types of anaemia. 
      
2. 12. GLUTATHIONE S-TRANSFERASE, PLACENTAL FORM 
(GST-P) 
Glutathione transferases (GST1) are a multigene family of phase II 
drug-metabolizing enzymes that catalyze the conjugation of glutathione with 
a range of endogenous and exogenous substrates (Armstrong, 1997;  Salinas 
and Wong, 1999). Soluble and membrane-bound GSTs are expressed in 
many tissues, and soluble GSTs constitute 1 to 5% of total cytosolic protein 
(Morgenstern et al., 1984; Sundberg et al., 1993 and Rowe et al., 1997). The 
expression of GSTs is regulated pre- and post-translationally in a tissue-
specific manner resulting in protein products that differ quantitatively in 
different tissues (Tu et al., 1983; Rowe et al., 1997). Tests express the 
highest amount of total GST protein per milligram cytosolic protein 
followed by the liver, brain, pancreas, adrenals, heart, and lung (DePierre 
and Morgenstern, 1983; Listowsky et al., 1998). Major GST-expressing 
tissues are the principal sites for drug and chemical metabolism indicative of 
the role of GSTs in the biotransformation of xenobiotics (Pabst et al., 1973; 
Armstrong, 1997). Studies on the tissue-dependent expression of GSTs have 
been used to infer other tissue-specific functions of the GSTs and to provide 
insight into tissue-selective damage by xenobiotics (Harrison et al., 1989; 
Sundberg et al., 1994). 
Much attention has been focused on the morphological, histochemical, 
and biochemical properties of the preneoplastic cells such as enzyme-altered 
foci and hyperplastic nodules (HNs) induced at early stages of chemical 
hepatocarcinogenesis (Farber et al., 1980). Among pre-neoplastic markers so 
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far found, epoxide hydrase (Levin et al., 1978), an isozyme of 
UDPglucuronosyl transferase, and a molecular form of glutathione (GSH) 
transferase (GSHTase; RX:glutathione R-transferase, EC 2.5.1.18; also 
called GSH S-transferase) were remarkable since their activities increased 
with the appearance of foci and HNs but decreased with the dedifferentiation 
of hepatomas (Sato et al., 1983). Nevertheless, most of the enzymatic 
activities were significantly high in normal hepatocytes and were easily 
inducible by drugs and carcinogens. Thus, specific preneoplastic markers are 
required for the analysis of the multi-step development of cancer cells. 
Several investigators have detected proteins that are increased in the 
preneoplastic cells induced in livers of rats administered with 
diethylnitrosamine and N-2-fluorenylacetamide (Eriksson et al., 1983; 
Sugioka et al., 1985). Eriksson et al. (1983) also observed increased 
polypeptides in isolated HNs induced by six models for the chemical 
hepatocarcinogenesis. 
  In studies of isozymic alterations during chemical 
hepatocarcinogenesis, especially of drug metabolizing enzymes (Sato et al., 
1983; Sato et al., 1981 and Kitahara et al., 1984), researchers  observed, by 
two dimensional gel electrophoretic analysis of the cytosolic proteins of the 
HN-bearing rat, that a polypeptide increased most markedly together with 
three other proteins. This polypeptide was identified immunochemically as 
the subunit of a neutral GSHTase that was purified from rat placenta. This 
placental form (GSHTase-P) was demonstrated to be localized in HNs and in 
foci positive for y-glutamyltransferase (GluTase; y-glutamyl transpeptidase, 
EC 2.3.2.2) (Sato et al., 1984). 
Because it is highly inducible during carcinogenesis, the rat 
glutathione transferase P (GST-P) gene which is strongly and specifically 
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expressed during chemical hepatocarcinogenesis, is considered to be an 
excellent tumor marker (Sato, 1989). Also the expression of GST-P was 
regarded as an important determinant of cancer susceptibility and a reliable 
marker of tumorgenesis (Hu et al., 1997.) 
It is worthy to mention that many research projects on N. sativa seeds 
have been carried out at the Department of Biochemistry, Faculty of 
Veterinary Medicine, U. of. K. The following are examples of the outcome 
of these projects:                                                    
In 2001 Imtithal reported that feeding N.sativa seeds to rabbit in a 
relatively moderate, high and very high doses clearly affected most of the 
tested biochemical parameters, and improved immunity. The effect was dose 
dependent, but with the application of highest dose the effect was slightly 
reduced.  
The effect of N.sativa on some immune reactions and the levels of 
blood proteins in diabetic rabbits have been studied by Eiman (2006). The 
results indicated that feeding N.sativa to diabetic rabbits showed clear 
tendency to increase plasma proteins concentrations specially the albumin 
fraction. The phagocytic activity of neutrophils was improved and the 
adverse effects of hypersensitivity reactions were reduced. 
 A study in broiler chicks (Monjid, 2006), showed that 
supplementation of three levels of N.sativa to the diet of broiler chicks, 
resulted in various changes on total cholesterol and triacylglycerols in blood 
and liver tissue. 
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CHAPTER THREE 
 
MATERIALS AND METHODS 
                         
MATERIALS 
3. 1. PREPARATION OF THE PLANT NIGELLA SATIVA (NS) 
 Three hundred grams of dry seeds of N. sativa were boiled in 1.6 liters 
of distilled water and the final volume was reduced to 200 ml by boiling. 
This extract was used for oral administration by a curved needle (Sondi 
needle, special needle for oral administration in rats). The dose determined 
was 0.6 ml which equivalents to 6 gram/ kg daily. 
 
3. 2. PREPARATION OF DIETHYLNITROSAMINE (DEN) 
 Diethylnitrosamine (obtained from Sigma Company) was dissolved in 
normal saline (1g in 25 ml). A dose of 200 mg/kg-body weight (as single 
dose intra peritoneally) was given to initiate hepatocarcinogenesis. (Sato et 
al., 1984). 
 
3. 3. EXPERIMENTAL ANIMALS 
Seventy five Wistar rats were used. They were kept under standard 
conditions of management and fed on local diet containing Dura, salt and 
liver as a source of protein and were allowed water ad libitum. The rats were 
divided into five groups 15 rats each (males and females in different ages 
with weights ranging between 150-200 g) as follows: 
Group A rats, were dosed with DEN (200mg/kg) intraperitoneally (i/p). 
Then 12 hours later the rats were given NS extract orally at a dose of  
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(6g/kg/day) for 8weeks. 
Group B rats (control group of DEN), were administered i/p with DEN at 
the first day and kept for 8 weeks. 
Group C rats (control group of NS), were dosed with NS extract daily per 
os for 8 weeks. 
Group D rats received DEN i/p in the first day. After 6 weeks they received 
N S extract daily per os for another 6 weeks. 
Group E rats were dosed orally with NS extract daily for 6 weeks, and then 
dosed intraperitoneolly with DEN. They were kept for another 6 weeks.  
 The rats in all experiments, were subjected to partial hepatectomy 
(pH) two weeks after the administration of DEN except group C, where pH 
was carried out two weeks after the administration of NS extract. 
 All animals were euthanized at the end of the experiments. Samples 
from liver and lung (target organs for DEN) were collected and preserved in 
10% neutral formalin for histopathology and  immunohistochemistry. 
 
METHODS 
3. 4. PARTIAL HEPATECTOMY (pH) 
 Rats were subjected to PH for promotion of carcinogenesis. At first, 
the animals were administered with diazepam intramuscularly (i/m) as 
premedication. Ten minutes later, rats were injected i/m with kitamine. 
About fifteen minutes rat had been in deep anesthesia. Surgical removal of 
two pieces from two different lobes of the liver has been done. The 
operation took about 20 minuets. Within one hour the rat recovered from 
anaesthesia.                                     
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3. 5. TISSUE PROCESSING 
 Liver and lung samples were processed in paraffin and sections were 
prepared. For histopathology and immunohistochemistry. 
The preparation of tissues and staining was carried out according to 
the methods described by Bancroft et al., (1996) through the following steps. 
Dehydration: 
 The formalin fixed tissues were labelled and dehydrated by using 
different ascending grades of methanol (70% for two hours and in  absolute 
alcohol overnight). 
Clearing: 
 The dehydrated material was then moved by using chloroform for 18 
hours. 
Impregnation: 
 The tissues were cleared and transferred to heated bath with paraffin 
wax. 
Embedding: 
 The imregnated tissue was transferred to paraffin wax at melting point 
(54-56° C) in moulds of suitable size. Then the blocks were allowed to cool 
and solidify. 
Microtomy: 
 Sections 4-6µm thick were cut using rotary microtome (Bairred and 
Tatlok ltd. England). 
Section manipulation: 
 The cut sections were fixed on glass slides and kept at 37° C for one 
hour. 
Staining of sections: 
 Before staining the sections; the tissues were freed of the wax using 
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xylene and rehydrated by descending grades of methanol (100%, 90% and 
70%). 
 The tissues were then cleared with xylene and stained with 
Hematoxylin for 15 minutes and with 1% eosin for 3-5 minutes, dehydrated 
again by ascending grades of methanol (70%, 90% and 100%) and cleared 
with xylene. 
Mounting: 
 The stained sections were covered with glass cover slips, fixed by 
Canada balsam and allowed to dry for 24 hours before examination. 
            
3. 6. IMMUNOHISTOCHEMISTRY FOR GST-P IDENTIFICATION 
 The avidin-biotin complex (ABC) method was used to demonstrate 
GST-P positive liver foci (Hsu et al., 1981). After deparafinization in xylene 
and alcohol the liver sections were treated by blocking endogenous 
peroxidase for 15 minutes at room temperature (26°c) and then rinsed with 
phosphate buffer saline (PBS, pH 7.4) 3 times for 5 minutes eachtime. The 
blocking of sections with normal goat serum (1:10) was conducted for 30 
minutes. Sections were then incubated with anti-GST-P (1:1000) for 90 
minutes and rinsed with PBS 3 times as mentioned above. Incubation of 
sections with peroxidase labeled polymer was conducted  for 30 minutes. 
After rinsing with PBS, the sections were incubated with DAB for 
approximately one minute, then rinsed with distilled water for 5 minutes, 
counterstained with Hematoxylin Mayer’s for one minute, rinsed again with 
tap water for 10 minutes, dehydrated in alcohol and cleared xylene. The 
sections were covered with cover slips. 
Ten sections from each group were taken randomly and examined 
under the microscope. Photographic shots were taken from each group, and 
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the number of foci were counted.  
 
3. 7. STATISTICAL ANALYSIS 
  The results were expressed as Mean ± Standard Error (S. E. M) using 
Microsoft Excel for windows 2003. The significance of difference in the 
number of foci between the control groups C and B and test groups were 
analyzed by Chi square test. 
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CHAPTER FOUR 
            
RESULTS 
                                                                    
4. 1. CLINICL OBSERVATIONS 
 Animals were inspected daily. Some rats (8, 8, 6, 7 and 4 from group 
A. B, C, D and E respectively) from each group died at the beginning of the 
experiments; the cause could not be established and no salient pathological 
abnormalities could be seen at necropsy or histopathological examination. 
 Surviving rats were apparently healthy and gained weight 
continuously throughout the experimental period. 
      
4. 2.  PATHOLOGICAL FINDINGS   
4. 2. 1. MACROSCOPIC LESIONS  
 No significant changes were observed in all organs of all groups of 
rats at postmortem.  
4. 2. 2 HISTOPATHOLOGICAL FINDINGS 
4. 2. 2. 1. LIVER 
 The main histopathological findings observed in liver and lung 
sections of each experimental group are presented in tables (1-10). Summary 
of histopathological change in all groups can be seen in table 11 and 12.  
 Most liver sections (Table 1, 3, 5, 7 and 9) showed evidence of 
degenerative changes mainly in the form of hepatocyte vacuolation; these 
have been graded as small (S), medium (M) and marked (D) vacuolations. 
Kupffer cell proliferation was seen in some cases (more in group C and least 
in group B and D). Dark brownish black deposits (pigmentation) were seen 
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in sections in the parenchyma and mostly in portal areas; these were more 
marked in liver sections of groups A, D and E. Marked sinusoidal dilatation 
was observed in some cases in all groups. In liver sections of rats receiving 
DEN (A, B, D, and E) focal irregularity of hepatocytes i. e. Increase in cell 
size with nuclear polymorphism and some binucleate and multinucleate cells 
were observed (Fig. 1, 2, 3, 4, 5, 6, 7, 8, and 9). 
However, some histopathological variations between the groups 
deserved to be mentioned.  
Group A showed that most of the vacuolations were small to medium. 
Pigmentation in liver parenchyma and portal areas was seen in most 
sections. 
In group B all sections showed small or small to medium vacuolations 
(90 %). Medium to large vacuoles were seen in about 10 % of sections (Fig.  
15). Variations in cell size and nuclear size were seen in 33.3 % of cases. 
Cells tended to be enlarged with large nuclei showing dense chromatin (Fig. 
16). Some bile ducts were enlarged (11.1 %) with epithelial hyperplasia and 
dilatation of portal vessels in 16.7 % of sections. 
Again in group C most vacuolations were small (70 %) or small to 
medium constituting 30 % of sections. Large vacuolations and sinusoidal 
dilatation were not seen. Nuclear pyknosis was seen in some cells. 
In group D most of the vacuolations were small to medium. Variations 
in nuclear size of hepatocytes was noticed in 78.9 % of sections (Fig. 18). 
Group E showed that vacuolations were mostly small. Kuppfer cell 
proliferation was seen in about 40 % of cases (Fig.19).                             
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Fig.1 Liver section (group A) showing cellular swelling and cytoplasmic 
vacuolation . H&E x100.   
 
 
Fig.2 Liver section (group A) showing brown pigmentation in hepatocytes. 
H&E x400. 
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Fig.3 Liver section (group E) showing large brownish hepatocyte deposits. 
H&E x400. 
 
 
 
Fig.4  Liver section (group D) showing sinusoidal dilatation. H&E x100. 
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Fig.5  Liver section (group E) showing a multinucleate hepatocyte (arrow). 
H&E x400. 
                                                                                                                                                                            
 
 
Fig.6 Liver section (group A) showing enlarged hepatocyte with nuclear 
margination. H&E  x400. 
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Fig.7 Liver section (group C) showing hepatocyte cytoplamic acidophilia 
and kupffer cell prolifertation. H&E x400. 
 
 
 
Fig.8 Liver section  (group D) showing enlarged binucleate hepatocytes 
(arrow). H&E x400. 
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Fig.9 Liver section (group E) showing cellular pleomorphism (arrows) and 
binucleate cell (arrow). H&E x400. 
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4. 2. 2. 2. LUNG 
 Lung sections in all groups, showed similar lesions with variable 
degrees. Congestion, peribronchial lymphoid hyperplasia and thickening of 
interstitial tissues were seen frequently. Emphysema was more evident in 
sections of groups B and C while goblet cell proliferation was mainly seen in 
group E. Foamy cells in alveoli and airways and mild suppurative bronchitis 
was observed in groups A and D (Fig.10, 11, 12, 13, and 14). 
 Some important histopathological variations between the groups are 
given blew 
In group A, goblet cell proliferation and bronchitis (mainly 
suppurative) are observed in three sections each. Large foamy cells 
(probably macrophages) were seen in alveoli and bronchi of three cases. 
Emphysema was not a feature in lung sections of this group. 
Most sections of group B showed peribronchial lymphoid hyperplasia 
which was very marked in two cases. Necrotic changes were observed in 
some sections (23.5 %) (Fig.17). Hyperplasia of bronchial epithelia and 
active goblet cells were seen in (30 %) of sections and no interstitial 
thickening seen. Bronchitis and presence of foamy cells were not seen. 
The control group C indicated that peribronchial lymphoid 
hyperplasia and emphysema were significant findings in this group together 
with congestion and goblet cell proliferation. Neutrophils were seen with 
peribronchial lymphoid cells. Bronchitis and foamy cells were not seen. 
Group D showed that peribronchial lymphoid hyperplasia and 
interstitial thickening were common in lung sections. Suppurative bronchitis 
and presence of foamy cells seen. Emphysema and increased goblet cells 
activity were not seen. 
Group E showed that similarly peribronchial lymphoid hyperplasia 
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and congestion were constant findings. Bronchitis, goblet cell proliferation 
and presence of foamy cells were more evident in this group. The bronchitis 
was mainly suppurative, with intra luminal appearance of neutrophils (Fig. 
20). 
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Fig.10 Lung section (group B) showing  peribronchial lymphoid hyperplasia. 
H&E 250. 
  
 
Fig.11 Lung section (group E) showing emphysema and congestion. H&E 
x100. 
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Fig. 12 Lung section (group B) showing emphysema and large foamy cell in 
a bronchus. H&E x250. 
 
 
 
Fig.13 Lung section (group E) showing interstitial thickening with 
mononuclear cell infiltration (pneumonitis). H&E x250.              . 
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Fig. 14 Lung section (group A) showing marked suppurative exudates in 
bronchi. H&E x250. 
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Table 1: Histopathological changes in the livers of group A 
rats.  
Rat No. Vac. Kpf. Prl. Sin. dil. Pig. Remarks 
AM 1/2 D   +/-  
AM 2/1 S   +/-  
AM 2/2 S   +  
AM 3/3 S   ++  
AF 1/2 S + + +  
AF 1/5 M + + +  
AF 2/3 M   +  
AF 3/1 S   +  
AF 4/2 M  + +/-  
AF 4/3 S +  +  
 
Vac.=Vacuolation                                            Kpf. Prl.= Kupffer cell proliferation  
Sin. dil.=Sinusoid dilatation                            Pig.= Pigmentation  
S.= small                     M.= medium                D.= marked              
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Table 2: Histopathological changes in the lungs of group A rats.  
Rat  
No. 
P.B.L.
H. 
Emph. Int. 
thick. 
Cong. Gob. 
cell 
Bronch. Foamy 
cells 
AM1/1   + + +   
AM 2/3   + +++ + + N +Bron. 
AM 2/5 +  + +    
AM 3/1 +  +     
AF 1/3 +   +    
AF 1/4 +/-  +     
AF 2/1 +  + +  + N/L + 
AF 2/2 +   +  +L/M/N  
AF 3/2 +  +/- + +   
AF 4/1 +  + +    
 
P.B.L.H.= Peri bronchial hyperplasia                   Emph.= Emphysema  
Int. thick.= Interstitial thickening                         Cong.= Congestion  
Gob. Cell= Goblet cell                                          Bronch.= Bronchitis 
N= Neutrophils            L= Lymphocytes              M= Macrophages 
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Table 3: Histppathological changes in the livers of group B rats. 
Rat No. Vac. Kpf. Prl. Sin. dil. Pig. Remarks 
BM 1/3 M +    
BM 2/4 S  +   
BM 3/2 S   +/-  
BM 4/1 S     
BM 5/1 S     
BM 5/2 S     
BF 1/4 S     
BF 2/2 S  +/-   
BF 3/3 M +  +  
BF 4/2 D     
 
Vac. = Vacuolation                                        Kpf. Prl. = Kupffer cell proliferation   
Sin. dil. = Sinusoidal dilatation                     Pig. = Pigmentation  
S.= small                 M.= medium                 D.= marked        
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Fig.15 Liver section (group B) showing large cytoplasmic vacuolations in 
hepatocytes. H&E x400. 
 
 
Fig. 16 Liver section (group B) showing variations in cell and nuclear size. 
Note the enlarged nuclei (upper left). H&E x 400. 
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Table 4: Histopathological changes in the lungs of group B rats.  
Rat  
No. 
P.B.L.
H. 
Emph. Int. 
thick. 
Cong. Gob. 
Cell 
Bronch. Foamy 
cells 
BM 1/2 + +  + +   
BM 2/2 +++ +  +    
BM 4/2 + +  +    
BM 5/4 +   +    
BF 1/1 +       
BF 1/3 +   +    
BF 2/4 + +  +    
BF 2/5  +   +   
BF 3/1 +++ +  ++ +   
BF 4/1 + +  +    
 
P.B.L.H.= Peribronchial hyperplasia                        Emph.= Emphysema  
Int.thick. = Interstitial thickening                              Cong. = Congesting  
Gob. Cell = Goblet cell                                              Bronch. = Bronchitis  
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Table 5: Histopathological changes in the livers of group C rats.  
Rat No. Vac. Kpf. Prl. Sin. Dil. Pig. Remarks 
CM 1/1 S     
CM 2/1 S     
CM 2/3 S   +  
CM 3/4 S     
CF 1/2 S +    
CF 1/4 S +    
CF 2/3 M +  +  
CF 3/1 M +  +  
CF 4/1 S +  +  
CF 4/2 M   +  
 
Vac. = Vacuolation                                    Kpf. Prl. = Kupffer cell proliferation  
Sin. dil  = Sinusoidal dilatation                 Pig. = Pigmentation 
S.= small                  M.= medium             D.= marked                                              
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Table 6: Histopathological changes in the lungs of group C rats.  
Rat 
No. 
P.B.L.H. Emph. Int. 
thick. 
Cong. Gob. 
cell 
Bronch. Foamy 
cells 
CM1/2 + +  +++ ++   
CM2/2 + L/N + +  +   
CM3/1  + +     
CM3/2  +      
CF 1/1  + + + +   
CF 1/3 +/- +      
CF 2/2 + + + + +   
CF 2/4 +  + +/- +   
CF 3/2 +/-L/N +  +    
CF 4/3 +/- + +     
 
P.B.L.H. = Peribronchial hyperplasia                    Emph. = Emphysema  
Int.thick = Interstitial thickening                           Cong. = Congestion   
Gob. Cell = Goblet cell                                          Bronch. = Bronchitis  
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Table 7: Histopathological changes in the livers of group D rats.  
Rat No. Vac. Kpf. prl Sin. dil. Pig. Remarks 
DM 1/1 S   +  
DM 2/1 S + +   
DM 3/2 D     
DM 4/2 S     
DM 5/1 S     
DM 5/4 S     
DM 6/3 S  +/- +/-  
DF 1/1 S   +  
DF 1/2 S  + +  
DF 2/4 S   +  
 
Vac. = Vaculoation                                      Kpf. Prl. = Kupffer cell proliferation  
Sin. dil = Sinusoidal dilatation                    Pig. = Pigmentation                                          
S.= small                 M.= medium               D.= marked                                               
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Fig. 17 Liver section (group D) showing cellular pleomorphism. H&E x400. 
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Table 8: Histopathological changes in the lungs of group D rats.  
Rat 
No. 
P.B.L.H. Emph. Int. 
thick. 
Cong. Gob. 
cell 
Bronch. Foamy 
cells 
DM1/3 +/-   +    
DM2/3 +  + +    
DM3/3   + +   +Alve.
DM4/3 +  +   +  
DM4/4   +/-     
DM5/3 +  + +    
DM6/2 +  +     
DF 1/3 +  + +  ±/N/Sup.  
DF 2/2 +  +/-   +N/Sup. + 
DF 2/3 +     + M/L + M/L 
 
P.B.L.H. = Peribronchial hyperplasia                            Emph. = Emphysema  
Int.thick. = Interstitial thickening                                   Cong. = Congestion   
Gob. Cell = Goblet cell                                                  Bronch. = Bronchitis     
N = Neutrophils                  M = Macrophages              L = Lymphocytes  
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Fig.18 Lung section (group D) showing  necrotic areas with suppurative 
exudates and suppurative bronchitis. H&E  x 250. 
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Table 9: Histopathological changes in the livers of group E rats. 
Rat No. Vac. Kpf. prl Sin. Dilt. Pigment. Remarks 
EM 1/1 S     
EM 2/3 M +  +  
EM 3/3 S     
EM 4/3 S +    
EF 1/1 S +  +  
EF 2/2 S   +  
EF 3/3 D +  +  
EF 4/2 D   +  
EF 5/3 S +  +  
EF 7/2 S +  +  
 
Vac. = Vacuolation                                             Kpf. Prol. = Kupffer cell proliferation          
Sin. dil = Sinusoidal dilatation                           Pig. = Pigmentation  
S.= small                    M.= medium                    D.= marked                                               
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Fig.19 Liver section (group E) showing cellular pleomorphism and kupffer 
cell proliferation .  H&E x400. 
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Table 10: Histopathological changes in the lungs of group E rats.  
Rat 
 No. 
P.B.L.H. Emph. Int. 
thick. 
Cong. Gob. 
cell 
Bronch. Foamy 
cells 
EM 1/3   ++ +  + + Alve.
EM 2/1 +  +/- +    
EM 3/1 +   +   +Bron.
EM 4/1 +   +    
EF 1/5 +  + + +   
EF 2/4 +   + +   
EF 3/2 +/-    + + Supp. +Bron.
EF 4/3 +     + Supp. +Bron.
EF 6/1      + Supp. +Bron.
EF 7/1 +   + +   
 
P.B.L.H. = Peribronchial hyperplasia                         Emph. = Emphysema       
Int. thick. = Interstitial thickening                              Cong. = Congestion  
Gob. Cell = Goblet cell                                              Bronch. = Bronchitis 
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Fig.20 Lung section (group E) showing suppurative bronchitis. H&E x400. 
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Comparison of histopathological results for all groups can be seen in tables 11 and 12.  
 
Table 11: Summary of histopathological changes in the livers of rats in 
all groups. 
Vacuolation % Group 
S M D 
Kpf.prL.
% 
Sin.dilt. 
% 
Pig. 
% 
A 60 30 10 30 30 100 
B 70 20 10 20 20 20 
C 70 30 Zero 50 Zero 50 
D 90 Zero 10 10 30 50 
E 70 10 20 40 Zero 70  
 
Kpf. Prl. = Kupffer cell proliferation          Sin. dil. = Sinusoidal dilatation             
Pig. = Pigmentation 
*No nuclear vacuolations seen in group C (grade D) (NS control). 
*Kupffer cell proliferation more in group C and least in group B and D. 
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Table 12: Summary of histopathological changes in the lungs of rats in 
all groups. 
Group P.B.L. 
H 
Emph. Int. 
thick
Cong. Gob. 
cell. 
Bronch. Foamy. 
Cells. 
A 80 Zero 80 80 30 30 20 
B 90 70 Zero 80 30 Zero Zero 
C 70 90 60 50 50 Zero Zero 
D 80 Zero 80 50 Zero 30 30 
E 80 Zero 30 70 40 40 50 
 
P.B.L.H. = Peribronchial lymphoid hyperplasia          Emph. = Emphysema 
Int.thick. = Interstitial thickening                                 Cong. = Congestion 
Gob.cell.= Goblet cell                                                  Bronch. = Bronchitis 
* Peri bronchial hyperpasia and interstitial thickening was seen in all groups 
*Emphyzema was significant in group C (NS control). 
*Goblet cell proliferation was mostly seen in group C but, no bronchitis was observed in 
this group.  
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4. 4. IMMUNOHISTOCHEMICAL FINDINGS  
The modified method of the medium-term bioassay of Ito based on 
two-step model of hepatocarcinogenesis was used as an assay system 
(Higgins and Anderson, 1931). This system was initially introduced in order 
to screen environmental and naturally occurring carcinogens. However, it 
was later used successfully for identifying different anti carcinogens 
(Tadashi et al., 1990 and Ito et al.,  1989). DEN was used as a carcinogen to 
initiate hepatocarcinogenesis because it is a proven and specific carcinogen 
for hepatocarcinogenesis (Morimura et al., 1993). 
The results of the immunohistochemical examination were 
summarized in Table 13 and the statistical analysis of the data is presented in 
tables 14 and 15. GST-P positive foci were stained brown in tissue sections 
and assumed different in shapes and sizes (Fig. 21, 22, 23, 24, 25 and 26). 
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Fig.21 Liver section (groupA) showing Positive GST-P foci (brown color). 
Avidin-biotin complex method (ABC) x250. 
 
 
Fig.22 Liver section (group D) showing small and large GST-P positive foci 
with individual hepatocyte involvement. ABC x100.   
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Fig.23 Liver section (group D) showing small and large GST-P positive foci. 
ABC x100. 
 
 
Fig.24 Liver section (group D)showing large irregular GST-P foci . ABC 
x100. 
 65
 
 
Fig.25 Liver section (group D) showing two large GST-P positive foci. ABC 
x100. 
 
 
Fig.26 Liver section (group D) showing four large rounded  GST-P positive 
foci. ABC x100. 
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Table 13 shows that group C scored the lowest number of foci while, 
group B scored the highest. Group D showed high number of foci almost 
similar to that in group B. Both groups A and E scored low number of foci 
(32 and 28 respectively) which are not largely different from each other. 
Table 14 shows the probability between the higher and lower groups. 
Generally, statistical analysis indicated similar probability of groups B and 
D (P= 0.000346619). While in group A and E there was differences 
(0.0061699 and 0.019076324) respectively.  
In Table 15, significant differences in the number of GST-P positive 
foci were observed between groups A B D & E and the control group C. The 
differences were very highly significant in group D & B which showed 
almost the same number of foci. No significant differences were observed 
between group B or D with either group A or E. 
Regarding the localization of GST-P enzyme, our study indicated that 
this enzyme has been localized in the cytoplasm and nucleus almost in all 
groups as well as in group C (Fig.27, 28 and 29). 
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Fig.27 Liver section (group E) showing GST-P positive hepatocyte with 
cytoplamic and nuclear localization of the enzyme. Note hepatocyte 
vacuolation. ABC x400. 
 
 
 
Fig.28 Liver section showing two hepatocytes with nuclear  localization of 
GST-P in (group E). Note the peripheral distribution of the enzyme (arrow). 
ABC x250.  
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Fig.29 Liver section (group D) showing a large GST-P positive focus. Note 
localization of the enzyme in nucleus and cytoplasm. ABC x 250.                                            
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Table 13: The number of GST-P positive foci in each experimental 
group. 
 
Rat No. Group A 
No. 7 
Group B 
No. 7 
Group C 
No. 9 
Group D 
No. 8 
Group E 
No. 11 
1 3 8 1 5 2 
2 2 3 0 4 2 
3 5 11 1 3 5 
4 3 2 0 2 3 
5 5 3 3 9 3 
6 4 4 0 4 3 
7 3 8 0 10 2 
8 2 3 0 12 3 
9 3 7 0 3 5 
10 2 7 0 3 0 
Total 32 56 5 55 28 
 
 
 
 
 
Table 14: The probability between the higher and lower groups.   
 
Group 1 (higher) Group 2 (lower) Probability (P) 
A C 0.0061699 
B C 0.000346619 
D C 0.000346619 
E C 0.019076324 
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Table 15: Results of Chi-square test of GST-P positive foci in the 
different experimental groups. 
 
Groups P-value 
A v C 0.00617 
B v C 0.00035 
D v C 0.00035 
E v C 0.01908 
  
B v A 0.26355 
D v A 0.26355 
  
A v E 0.63921 
B v E 0.121335 
D v E 0.121335 
  
B v D 1.000 
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CHAPTER FIVE 
 
DISCUSSION  
 
Cancer has become a major cause of mortality world-wide (Gruddy, 
1991). A great majority of human and animal cancer are attributed to 
environmental factors (Benjamin et al., 1990). Continuous  effort is now 
being exerted in search for cheap and safe medicines and preventive 
methods in order to treat cancer and reduce its mortality and related side 
effects. Many investigations are now being carried out to find naturally 
occurring compounds which can suppress or prevent the process of 
carcinogenesis (Wargovich et al., 1988; Thapliyal et al., 2002). 
Much attention has been directed towards the seeds of N. sativa which 
are rich and diverse in chemical components. Preparations of this plant has 
been accredited for having many useful therapeutic properties and activities. 
Nigella sativa has been used for treating respiratory, gastrointestinal tract 
and skin diseases, and is known to activate the immune system and have an 
anti carcinogenic effect. It is used as a carminative and a food additive and 
was  found to be effective against common cold (Lautenbacher, 1997; 
Merfort et al., 1997; Eschborn, 1997; Aboutabl et al., 1986; Salomi a et al., 
1992 and Shoieb et al.2003). 
In the present study diethylnitrosamine (DEN), a known hepatic 
carcinogen (Sato et al., 1984), was used to induce neoplastic transformation 
in liver cells of rats. Nitrosamine can be synthesized from nitrates and 
secondary amines in the gastrointestinal tract and produce, experimental 
liver tumours. Because nitrites (and nitrate) may be used as common food 
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additive, the probability that some formed nitrosamines may be carcinogenic 
for man has been raised. 
In this study, the hepatoprotective effect of NS against DEN has been 
investigated in rats using different approaches. Rats receiving DEN in the 
different groups (A, B, D, and E) didn`t show any gross abnormalities in the 
liver or other organs suggestive of neoplastic transformation or any 
inflammatory or necrotic changes. Although salient macroscopic changes 
were not seen, some microscopic lesions in the liver have been observed. 
The enlarged hepatocytes with hyperchromatic nuclei, the nuclear 
polymorphism with appearance of binucleate and multinucleate cells in liver 
sections of all groups receiving DEN, may indicate cell dysplasia which is 
considered as a premalignant change. These changes may be related to DEN 
and might have been enhance by the partial hepatectomy performed in the 
rats. It is known that hyperplasia and hypertrophy occur in residual 
hepatocytes following partial hepatectomy. The changes described above 
can not be attributed to NS as no such changes were seen in control rats 
receiving NS only. One significant observation  in these rats (controls) is the 
marked hyperplasia of kupffer cells, which may indicate an active 
immunological status as these cells belong to the mononuclear-phagocytic 
system.  Moreover, marked hepatocyte vacuolations were not seen in this 
group. 
The question arises as to why frank neoplastic changes could not be 
induced by DEN. It is conceivable that changes of the cell from normal state 
to neoplastic state is a long process involving several stages. Late changes 
show evidence of cellular dysplasia which may represent growth of partially 
transformed cells not yet achieving full neoplastic status. It is also known 
that tumor formation depends on the dose and /or  duration of the carcinogen 
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to which the individual is exposed. Dose and duration of DEN might not 
have been adequate in our case as to cause visible neoplastic growth.  
The lung also could be a target organ for DEN and hence lung 
sections were examined; no evidence of neoplastic changes could be seen in 
all experimental rats. However, peribronchial lymphoid hyperplasia and 
focal interstitial thickening (focal pneumonitis) have been noticed in sections 
of all groups including controls, but bronchitis was not seen  in the control 
rats. 
The present results showed that lesions suggestive of neoplastic 
changes (cell dysplasia) have been observed microscopically in the liver of 
rats receiving DEN. Irrespective of the protocol of NS administration. 
Therefore, the immunohistochemical study was confined  to the liver only. 
Much attention has been focused on morphological, histological and 
biochemical properties of preneoplastic cells such as enzymes-altered foci 
(foci which indicate the presence of enzyme) and hyperplastic nodules 
induced at early stages of chemical hepatocarcinogenesis (Farber and 
Cameron,1980). One of these enzymes is GST-P. The rat GST-P, which is 
related to human GST-π in enzymatic and immunological properties, is a 
detoxifying enzyme in liver and has many isoforms. GST-P is present in 
small quantities in rat tissues such as lung, kidney, testis, spleen and 
placenta, but is present only in trace amounts in normal livers (Sugioka et 
al.,1985; Sato, 1988). Another study indicated that GST-P is weakly 
expressed in rat tissues, including lung, kidney, spleen, and placenta. GST-P 
is not detected in normal liver, but it is markedly and specifically increased 
during early stages of hepatocarcinogenesis; it can be detected in single liver 
cells as early as 2–3 days after the administration of a chemical (Farber, 
1984; Sato,1989). Therefore, this enzyme has been used as a reliable tumor 
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marker for both chemically induced and spontaneously arising precancerous 
lesions and hepatomas in experimental carcinogenesis studies. The induction 
of GST-P occurs primarily at the transcriptional level (Sugioka et al ,1985).                        
In the present investigation, the modified method of the medium-term 
bioassay of Ito et al based on two-step model of hepatocarcinogenesis was 
used as an assay system (Ito et al., 1988). This system was initially 
introduced in order to screen environmental and naturally occurring 
carcinogens. However, it was later used successfully for identifying different 
anti carcinogens (Tadashi et al.,1990; Ito et al., 1989). DEN was used to 
initiate hepatocarcinogenesis because it is a proven and specific 
hepatocarcinogen (Morimura et al., 1993).  
 The comparable high number of GST-P positive foci in groups B and 
D is expected. In the former group DEN, the carcinogenic agent, was given 
alone and its action was not checked by NS extract. In the latter group (D) 
NS seems to have no inhibitory effect on DEN-mediated GST-P expression. 
This is probably because NS was administered late (6 weeks) after DEN, 
when the early stages of hepatocarcinogenesis has already passed and foci 
began to formulate. 
 On the other hand, the results indicate that NS had a significant 
inhibitory effect on DEN–mediated GST-P expression when administered 
few hours after DEN group (A) or when DEN was given after six weeks 
treatment with NS group (E). This indicates that NS suppresses the early 
stages of DEN carcinogenesis and that the residual effect of NS, given for 
along period, could protect against DEN for some time after cessation of NS 
treatment.                                                              
Two studies in rats have demonstrated a significant inhibitory effect 
against DEN by an indigenous medicine comprising Nigella sativa, 
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Hemidesmus indicus and Smilax glabra (Iddamaldeniya et al., 2003; 
Iddamaldeniya et al., 2006). Another study has also shown the anti-tumor 
principles from Nigella sativa and Crocus sativus on chemical 
carcinogenesis in mice (Salomi et al., 1991). Findings from these studies 
support our trial to use this plant in the treatment of cancer. In addition, NS 
was found to be cytotoxic to several cancer cell lines (Salomi a et al., 1992) 
and its active ingredients thymoquinone and dithymoquinone were found to 
be cytotoxic to several multi-drug resistant human cell lines (Worthen et al., 
1998 ). 
The few GST-P positive foci seen in the control group (C) is difficult 
to explain but may probably be due to the  action of a latent stimulus or 
because of NS administration itself (abnormal liver).  This agrees with the 
studies mentioned above (Farber, 1984; Sato,1989) and indicates that GST-P 
can be present in normal livers. 
Regarding the localization of GST-P enzyme, it was reported that the 
GST-P enzyme can be localized in the cytoplasm, mitocondira, lysosomes 
and nucleus of various cancer cells including colorectal cancer and bladder 
carcinoma (Wen et al., 2000; Chen M et al.,1998) In our study we also 
found that this enzyme has been  localized in cytoplasm and nucleus. 
The mechanism by which N. sativa mediate its anti-carcinogenic 
effect is not clear. This effect may be by one or both of the following 
mechanisms:  
(1) cytotoxicity. 
(2) anti-oxidant activity of N.sativa.                           
Recent in vitro studies have demonstrated that N. sativa can be 
cytotoxic to several cancer cell lines (Salomi b et al., 1992). Thymoquinone 
and dithymoquinone, two isolated active components of N. sativa, have also 
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been shown to be cytotoxic to several parental and multi drug resistant 
human cancer cell lines (Worthen et al., 1998). Further Nigella sativa and 
Hemidesmus indicus have been shown to possess anti-oxidant activities  
(Alam et al., 1998 and Ravishankara et al., 2002).                  
       In conclusion, this study suggests that NS has the potential as an 
antineoplastic plant medicine. 
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CONCLUSION 
 
(1) Diethylnitroasmine has a carcinogenic effect on rat liver. 
(2) The water extract of Nigella sativa has a protective effect against    
Diethylnirosamine induced hepatocarcinogenesis in rats especially when 
administered before or shortly after the carcinogen. 
(3) Liver sections of rats in all groups receiving Diethylnitrosamine showed 
changes indicative of cell dysplasia (preneoplastic changes). 
(4) Compared to rats injected with DEN only, the GST-P positive foci were 
significantly decreased in animals given NS specially when administered 
few hours after DEN or given for 6 weeks before injection of DEN. 
(5) Based on the present findings, it can be concluded that routine 
histopathology is not adequate to detect with confidence early neoplastic 
changes in the liver or other tissues. Immunohistochemical techniques 
however are very helpful for detection and conformation of such changes. 
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RECOMMONDATIONS 
 
(1) Further studies should be carried out using different Diethylnitrosamine 
doses and NS treatment protocols. 
(2) The effect of Diethylnitrosamine on lung, as a possible target organ, and 
effect of NS extract needs further attention. 
(3) A long term study should be carried out to examine the effect of this 
extract against DEN induced hepatocarcinogenesis. 
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